The agency extended the indication of the advanced breast cancer drug palbociclib (Ibrance, Pfizer) to include male patients.
FDA Approvals
FDA Expands Use of Breast Cancer Drug to Men
The agency extended the indication of the advanced breast cancer drug palbociclib (Ibrance, Pfizer) to include male patients.
FDA Approvals
